• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.

作者信息

Gach Agnieszka, Wyka Krystyna, Malecki Maciej T, Noczynska Anna, Skupien Jan, Nazim Joanna, Szalecki Mieczyslaw, Bodalski Jerzy, Sieradzki Jacek, Mlynarski Wojciech

机构信息

Department of Pediatrics, Medical University of Lodz, 38/50 Sporna St., 91-738 Lodz, Poland.

出版信息

Diabetes Care. 2007 Aug;30(8):2080-2. doi: 10.2337/dc06-2440. Epub 2007 May 2.

DOI:10.2337/dc06-2440
PMID:17475937
Abstract
摘要

相似文献

1
Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.由KCNJ11基因突变导致的永久性新生儿糖尿病病程较长的患者中胰岛特异性抗体血清转化情况。
Diabetes Care. 2007 Aug;30(8):2080-2. doi: 10.2337/dc06-2440. Epub 2007 May 2.
2
Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation.起病时存在胰岛细胞抗体阳性和 Kir6.2 激活突变的新生儿糖尿病。
Diabetes Res Clin Pract. 2009 Nov;86(2):e25-7. doi: 10.1016/j.diabres.2009.07.011. Epub 2009 Aug 18.
3
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.一名因KCNJ11激活突变导致永久性新生儿糖尿病的婴儿从皮下注射胰岛素转换为口服格列本脲的门诊过渡治疗。
Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24.
4
Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.一名因KCNJ11基因突变导致新生儿糖尿病的4个月大女孩从胰岛素治疗转换为格列本脲治疗。
Pediatr Diabetes. 2007 Aug;8(4):235-8. doi: 10.1111/j.1399-5448.2007.00231.x.
5
Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.KCNJ11基因G53D突变所致永久性新生儿糖尿病的磺脲类药物治疗：血糖控制及神经功能改善
Diabetes Care. 2007 Nov;30(11):e108. doi: 10.2337/dc07-1196.
6
KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.KCNJ11激活突变与发育迟缓、癫痫和新生儿糖尿病综合征以及其他神经学特征相关。
Eur J Hum Genet. 2006 Jul;14(7):824-30. doi: 10.1038/sj.ejhg.5201629. Epub 2006 May 3.
7
Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes.对一名被诊断为新生儿糖尿病的7岁儿童的高血糖治疗。
Diabetes Care. 2006 Jun;29(6):1458. doi: 10.2337/dc06-0487.
8
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.携带新型KCNJ11基因突变的家族中糖尿病的可变表型谱。
Diabet Med. 2008 Jun;25(6):651-6. doi: 10.1111/j.1464-5491.2008.02443.x.
9
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.对于因KCNJ11激活[校正后]突变导致永久性新生儿糖尿病的成年患者，转换为磺脲类药物治疗：胰岛素敏感性改善的证据。
Diabetes Care. 2007 Jan;30(1):147-9. doi: 10.2337/dc06-1628.
10
[Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].婴儿糖尿病可用磺脲类药物治疗以替代胰岛素。
Ugeskr Laeger. 2009 Jun 1;171(23):1923-4.

引用本文的文献

1
Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.先天性β细胞缺陷与胰岛自身免疫标志物无关，即使在 1 型糖尿病的高遗传风险背景下也是如此。
Diabetologia. 2022 Jul;65(7):1179-1184. doi: 10.1007/s00125-022-05697-3. Epub 2022 Apr 30.
2
Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation.一名患有新型KCNJ11突变的永久性新生儿糖尿病患者磺脲类药物治疗成功。
Korean J Pediatr. 2015 Aug;58(8):309-12. doi: 10.3345/kjp.2015.58.8.309. Epub 2015 Aug 21.
3
Genetics and pathophysiology of neonatal diabetes mellitus.
新生儿糖尿病的遗传学与病理生理学
J Diabetes Investig. 2011 Jun 5;2(3):158-69. doi: 10.1111/j.2040-1124.2011.00106.x.
4
Challenges in diagnosing type 1 diabetes in different populations.不同人群中 1 型糖尿病诊断的挑战。
Diabetes Metab J. 2012 Apr;36(2):90-7. doi: 10.4093/dmj.2012.36.2.90. Epub 2012 Apr 17.
5
Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.新生儿糖尿病：不断增加的基因列表有助于改善诊断和治疗。
Curr Diab Rep. 2011 Dec;11(6):519-32. doi: 10.1007/s11892-011-0234-7.
6
HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions.HbA(1c) 水平在 1 型糖尿病患儿中具有季节性变化，且与天气条件有关。
Diabetologia. 2011 Apr;54(4):749-56. doi: 10.1007/s00125-010-2013-4. Epub 2010 Dec 25.
7
Diagnosis and treatment of neonatal diabetes: a United States experience.新生儿糖尿病的诊断与治疗：美国的经验
Pediatr Diabetes. 2008 Oct;9(5):450-9. doi: 10.1111/j.1399-5448.2008.00433.x. Epub 2008 Jul 25.
8
Neonatal diabetes mellitus.新生儿糖尿病
Endocr Rev. 2008 May;29(3):265-91. doi: 10.1210/er.2007-0029. Epub 2008 Apr 24.